We investigated whether the high mobility group B 1 (HMGB1), an abundant nuclear protein in all mammalian cells, affects HIV-1 transcription. Intracellular expression of human HMGB1 repressed HIV-1 gene expression in epithelial cells. This inhibitory effect of HMGB1 was caused by repression of long terminal repeat (LTR)-mediated transcription. Other viral promoters/enhancers, including simian virus 40 or cytomegalovirus, were not inhibited by HMGB1. In addition, HMGB1 inhibition of HIV-1 subtype C expression was dependent on the number of NFB sites in the LTR region. The inhibitory effect of HMGB1 on viral gene expression observed in HeLa cells was confirmed by an upregulation of viral replication in the presence of antisense HMGB1 in monocytic cells. In contrast to what was found in HeLa cells and monocytic cells, endogenous HMGB1 expression did not affect HIV-1 replication in unstimulated Jurkat cells. Thus, intracellular HMGB1 affects HIV-1 LTR-directed transcription in a promoter-and cell-specific manner.
Introduction
Transcription of the HIV-1 genome is regulated by the interaction of viral long terminal repeat (LTR) cis-acting sequences with a complex of viral regulatory proteins and cellular transcription factors (Gaynor, 1992) . The complex interplay between the cellular and/or viral proteins and the LTR leads to an up-/down regulation of transcription, which in turn may play a role in the control of HIV-1 latency vs active replication. The LTR can be divided into a modulatory region containing a negative regulatory element (NRE), an enhancer/promoter region, and sequences coding for a RNA stem-loop structure termed TAR. The interaction of several constitutive and inducible transcription factors with the enhancer/promoter element and the modulatory region (reviewed in Pereira, 2000) leads to a basal level of transcription with the majority of these transcripts terminating prematurely. Transcription elongation is then controlled by the interaction of TAR element with the viral trans-activator protein Tat in conjunction with a cellular kinase (for a review, see Karn, 1999) . It has recently been suggested that in addition to stimulating transcriptional initiation, NFB can also stimulate elongation from the HIV-1 LTR in activated T cells (West et al., 2001) .
Sequence polymorphisms in transcription factor binding sites within the LTR have been linked to subtype specific sequences in the gag and env genes (Johansson et al., 1995; Gao et al., 1996; Montano et al., 1997; Naghavi et al., 1999a; Jeeninga et al., 2000; Blackard et al., 2000) . In addition, several groups have correlated considerable intrasubtype sequence variability (Estable et al., 1996 (Estable et al., , 1998 as well as intersubtype polymorphisms (Montano et al., 1997 (Montano et al., , 1998 (Montano et al., , 2000 Verhoef et al., 1999; Jeeninga et al., 2000) within the LTR to divergent transcriptional regulation of HIV-1. We have reported that the promoter/enhancer activity of HIV-1 subtype C on average was higher than the activities of the other subtypes (Naghavi et al., 1999b (Naghavi et al., , 2001 and that it correlated with the presence of the third potential NFB site previously described (Johansson et al., 1995; Salminen et al., 1996) as well as an alternative core-NRE (Naghavi et al., 1999b (Naghavi et al., , 2001 .
The high mobility group (HMG) proteins were discovered as abundant heterogeneous eukaryotic nonhistone components of chromatin (Goodwin et al., 1973) . They were named for their rapid migration properties on polyacrylamide gels. Based on their sizes, sequence similarities, and DNA-binding characteristics, HMG proteins can be divided into three groups: HMGB, HMGA, and HMGN (Bustin, 2001) , previously called HMG-1/2, HMG-I/Y, and HMG-14/17, respectively (reviewed by Bianchi and Beltrame, 2000) . HMGB proteins have a molecular mass of approximately 25 kDa and are characterized by the presence of three different domains: the N-terminal A-domain, the central B-domain (also referred to as HMG box A and B) each of 80 -90 highly basic amino acid residues, and the Cterminal acidic tail (for a review see Bustin, 1999) .
HMGB serves as a DNA-bending, -wrapping, and -looping factor that can be required for transcription, DNA repair, and recombination (Bianchi and Beltrame, 2000) . Beyond this intracellular function, HMGB1 also has an extracellular function in macrophages (for a review see Muller et al., 2001) and plays an important role in inflammation (Wang et al., 1999) and tumor metastasis (Taguchi et al., 2000) . Despite the accumulating data on the extraordinary functions of HMGB1, very little is known about the impact of HMGB1 on HIV-1 life cycle. The HMGD which previously was suggested to be a Drosophila homologue of vertebrate HMGB (Wagner et al., 1992) has recently been shown to interact with double-stranded RNA such as the TAR and Rev proteinbinding element (RBE) of HIV-1 (Arimondo et al., 2000) . Based on sequence homologies, the dorsal switch protein (DSP1) in Drosophila (Lehming et al., 1994) has been suggested to be the equivalent of vertebrate HMGB (Canaple et al., 1997) . Similar to DSP1 (Lehming et al., 1994) , the HMG box in HMGB1 can also interact with the Rel domain of Dorsal (Brickman et al., 1999; Decoville et al., 2000) . Thus, it is conceivable that HMGB1 can also interact with the Rel protein NFB, which in turn can regulate HIV-1 LTR directed transcription.
In this study, we investigated whether the intracellular overexpression of HMGB1 had an effect on HIV-1 transcription. We found that human HMGB1 repressed HIV-1 gene expression in monocytes and cultured epithelial cells through inhibition of the LTR mediated transcription in a promoter-, and cell-specific manner.
Results

HMGB1 represses HIV-1 gene expression in epithelial cells
To test the effect of intracellular HMGB1 on HIV-1 gene expression, the infectious proviral HIV-1 molecular clone pNL4-3 (Adachi et al., 1986) was transiently transfected, in the absence or presence of various concentration of the pcDNA-HMGB1-sense (HMGB1-S), pcDNA-HMGB1-antisense (HMGB1-A), or the empty pcDNA vector, into HeLa cells. The extracellular p24 gag and the human growth factor (hGH) levels were then determined at various times posttransfection in triplicate samples in at least two independent experiments. In the presence of the HMGB1-S plasmid, we observed a reduction of p24 gag production from the pNL4-3 at 24 h posttransfection ( Fig. 1a and c). This inhibitory effect of HMGB1 was dose dependent with a maximum of fivefold reduction at Ն5 g of the HMGB1-S plasmid and was seen when the levels were normalized to internal control hGH. The repressive effect of HMGB1 decreased at Ն48 h posttransfection to about two-to threefold at 72 h posttransfection ( Fig. 1b and d) . No inhibition of gene expression was observed from pNL4-3 in the presence of the empty pcDNA plasmid ( Fig. 1a and b) or the antisense HMGB1 plasmid ( Fig. 1c and d) , indicating that the inhibitory effect observed was induced by the ectopic production of the HMGB1.
HMGB1 represses HIV-1 LTR-mediated transcription
To investigate whether the HMGB1 repressive effect was at the level of LTR-directed transcription, a CAT reporter gene construct containing HIV-1 LTR derived from subtype B virus (pNLCATB) (Tan et al., 1995) was cotransfected, in the presence or the absence of different amounts of HMGB1-S or HMGB1-A, into HeLa cells. Fig. 2 represents the mean CAT values normalized to hGH numbers at 24 h posttransfection. Ectopic overexpression of HMGB1 inhibited transcription directed from the PNLCATB HIV-1 LTR ( Fig. 2a ). Again, the inhibitory effect of HMGB1 was dose dependent with a maximum inhibition of 3.4-fold at Ն7 g of the HMGB1-S plasmid. Since the basal transcription levels were low, we further looked for the effects of HMGB1 in the presence of the viral protein Tat (Fig. 2b ). HeLa cells constitutively expressing Tat, HLtat (Schwartz et al., 1990) , were used for transfections in the Tat transactivation experiments. An earlier (visible already at 1 g of the HMGB1-S plasmid) and more profound inhibitory effect of HMGB1, up to 9.2-fold at 3 g of the HMGB1-S vector, was detected in the presence of Tat. However, an obvious toxic effect was observed at higher concentrations of cotransfected DNA ( Fig. 2b at 5 g) in the presence of Tat. These findings further corroborate that ectopic HMGB1 expression was responsible for the downregulation of viral gene expression.
HMGB1 does not repress transcription derived from other viral promoters
In order to analyze the effect of HMGB1 on other viral promoters, HeLa cells were transiently transfected with cytomegalovirus (CMV) promoter reporter gene containing constructs pCMVCAT (Zhao et al., 1996) and pCMVHGH (Ramirez-Solis et al., 1990) or with the pSV-␤-galactosidase (Promega) control vector, which contains a simian virus 40 (SV40) promoter/enhancer. As described above, the transfections were done in the presence or the absence of the internal control plasmid pCMVHGH, HMGB1-S, Fig. 1 . HMGB1 represses HIV-1 gene expression in HeLa cells. p24 gag activity for pNL4-3, normalized to the hGH numbers produced from the internal control plasmid (pCMVHGH), in the absence (indicated as no effector) or the presence of various amount of the HMGB1 sense (HMGB1-S) or the empty pcDNA plasmid at 24 h (a) and 72 h (b) posttransfection. The standard deviations (SD) represent the median of three separate transfections. Cell supernatant from untransfected HeLa cells were used as a negative control (not shown). Mean p24 gag activity for the infectious clone normalized to the mean hGH numbers, in the absence or presence of different concentration of HMGB1-S or the antisense HMGB1 plasmid (HMGB1-A) at 24 h (c) and 72 h (d) posttransfection. HMGB1-A, or pcDNA. The mean CAT, and hGH values detected at 24 h posttransfection are shown in Fig. 3 . In the presence of pCMVHGH, the CAT activity produced from pCMVCAT were equal in the absence or the presence of the various amounts (1-5 g) of the HMGB1-S or the antisense HMGB1 plasmid (Fig. 3a) , indicating that HMGB1 had no effect on the CMV promoter. As is shown in Fig. 3b . no gross differences were observed at the level of the hGH activity in the same experiment, which further confirmed that HMGB1 had no effect on CMV promoter as seen in Fig. 3a . Because the expression of both CAT and hGH are under the control of the same CMV promoter, some of the transfections were done only in the presence of pCMVHGH or pCMVCAT to exclude a possible competition for transcription factors. In the absence of the internal control pCMVHGH, the level of CAT transcription directed by CMV promoter was equal in the absence or the presence of different concentration of the input HMGB1 plasmids (Fig.  3c ). In the absence of pCMVCAT, the hGH activity was similar in the absence or the presence of the various HMGB1 plasmids at different concentrations (Fig. 3d ). In this experiment, a slight (1.5-fold) increase of hGH activity was seen in the presence of HMGB1 sense cotransfection, but this effect was not dose dependent.
The mean ␤-galactosidase activity under the control of an SV40 promoter/enhancer was normalized to hGH values detected at 48 h posttransfection. The results are shown in Fig. 3e . In comparison to the CMV promoter activity, a more pronounced stimulatory effect (threefold) was observed for the SV40 promoter/enhancer activity in the presence of 1-5 g of the HMGB1 sense plasmid. The ␤-galactosidase production in the presence of different amounts of the HMGB1 antisense vector or the empty control pcDNA plasmid was similar to that of pSV-␤-galactosidase alone (indicated as no effector), indicating that the upregulatory effect detected here was induced by the ectopic production of HMGB1. Thus, the inhibitory effect induced by ectopic production of HMGB1 on HIV-1 LTR mediated transcription was not observed in the context of other viral promoters/enhancers such as those of CMV or SV 40. In contrast, HMGB1 stimulated transcription from the SV 40 promoter/enhancer and to a lesser extent also the CMV promoter.
HMGB1 represses HIV-1 subtype C expression in HeLa cells, dependently of the number of NFB sites in the LTR of these strains
HIV-1 subtype specific enhancer sequences such as different number of NFB sites have been suggested to play a role in divergent LTR-mediated transcription (Gao et al., 1996; Montano et al., 1997 Montano et al., , 1998 Montano et al., , 2000 Verhoef et al., 1999; Naghavi et al., 1999b Naghavi et al., , 2001 Blackard et al., 2000; Jeeninga et al., 2000; Hunt et al., 2001) . To analyze whether the higher number of NFB sites (three sites instead of two) present in the LTR of subtype C viruses had any impact on the HMGB1 repression of HIV-1 gene expression, a 12 bp mutation which replaced the extra NFB site (NFBI, position Ϫ79 to Ϫ68) was introduced into the LTR sequences from a previously described (Naghavi et al., 1999b) subtype C strain (GM6439:1C). The relevant part (Ϫ174 to ϩ46) of the LTR alignment of the consensus subtype B and the wt-, (GM6439C-wt) or mutant (GM6439C-mB, containing only two functional NFB sites) subtype C is presented in Fig. 4 . These LTR clones were then tranferred into infectious clone pNL4-3 and tested in single round replication assay in the absence or the presence of HMGB1 in HeLa cells. The mean p24 gag activity normalized to the mean hGH numbers for the wt subtype B (pNL4-3) and the wt or mutant subtype C (pNL6439C-wt and pNL6439C-mB, respectively) viruses, in the presence of 5 g of the HMGB1-S or HMGB1-A at 24 and 48 h posttransfection are shown in Fig. 5 . In the presence of the antisense HMGB1, the viral activity of wt or mutant subtype C virus was 1.4-fold higher than that of the control subtype B (pNL4-3) virus as well as the same control virus in the absence of an effector plasmid (indicated as no effector) at 24 h (Fig.  5a ) posttransfection. Again, ectopic expression of HMGB1 repressed the viral activity of the pNL4-3 by 3.4-and 4.1-fold at 24 h ( Fig. 5a ) and at 48 h posttransfection ( Fig. 5b) , respectively. The same pattern of viral activity at the various times posttransfection was found for the mutant subtype C virus in the presence of HMGB1-S but not for the wt virus from the same strain. The p24 gag activity of the pNL6439C-wt virus was more or less similar in the presence of the HMGB1 sense and the antisense plasmids, indicating no inhibitory effect of HMGB1. Thus, it seems that the extra NFB site might overcome the inhibitory effect of HMGB1 on HIV-1 subtype C replication. Fig. 4 . Nucleotide sequence alignment of HIV-1 LTR, including the relevant part core-NRE, enhancer/promoter region, and the TAR element (Ϫ174 To ϩ46) of the complete alignment (Ϫ382 to ϩ113). The most important transcription factor binding sites involved in viral gene expression are indicated (i.e., core-NRE, ETS/RBF-1, LEF, RBF-2, NFB, SP1, TATA, and TAR). The letters before the sample code (GM) denote the country of origin of the virus strain (Gambia). The letter after the sample code indicates the HIV-1 subtype (subtype B and C) based on the LTR region. wt or NFBI-mutant (mB) subtype C LTRs are marked. Deviations from the subtype B consensus LTR sequences are indicated.
HMGB1 does not repress HIV-1 replication in unstimulated Jurkat cells
In order to assess whether the repression of HIV-1 expression observed by intracellular HMGB1 in HeLa cells could also be seen in T cells, Jurkat cells were cotransfected with pNL4-3 in the presence or the absence of HMGB1-S or HMGB1-A vector. Mean p24 gag concentration for the infectious clone at various times posttransfection (day 1 to day 3), in the presence or the absence of 5 g HMGB1 vectors are shown in Fig. 6a . The level of viral replication in the presence of HMGB1-S and HMGB1-A was unchanged to that of the infectious clone alone at different time points, indicating that HMGB1 did not inhibit viral replication in unstimulated Jurkat cells. This finding may suggest an inhibitory effect of HMGB1 through NFB because there is no activated NFB in the nucleus of unstimulated Jurkat cells in contrast to HeLa cells.
Antisense HMGB1 upregulates HIV-1 replication in monocytic cells
Because as in HeLa cells, activated NFB is also found in the nuclei of monocytes, we tested the role of HMGB1 on HIV-1 replication in the THP-1 monocytic cell line. THP-1 cells were cotransfected with pNL4-3 in the presence or absence of HMGB1-S or HMGB1-A. Fig. 6b represents the mean p24 gag concentration at day 1 to day 3 posttransfection. In the presence of 5 g of the HMGB1-S vector, the level of p24 activity was reduced at day 2 but was more or less similar to that of the pNL4-3 alone at day 3 (Fig. 6b) . Notably, a 4.3-fold upregulation of viral replication was observed in the presence of 5 g of the antisense HMGB1 plasmid at 24 h posttransfection. This upregulatory effect of HMGB1-A on the viral replication was decreased at Ն48 h posttransfection to 1.4 -3.4-fold. HMGB1 mRNA is constitutively expressed in monocytes/macrophages (Wang et al., 1999) . Thus, HMGB1-S cotransfection might not add addi- Fig. 5 . HMGB1 represses HIV-1 subtype C expression in HeLa cells, dependently of the number of NFB sites in the LTR of these strains. Mean p24 gag activity normalized to the mean hGH numbers for the control wt subtype B (pNL4-3) and the wt or mutant subtype C (pNL6439C-wt and pNL6439C-mB, respectively) viruses, in the presence of 5 g of the HMGB1-S or HMGB1-A at 24 h (a) and 48 h (b) posttransfection. p24 gag activity for the reference plasmid pNL4-3 in the absence of HMGB1 vectors is indicated as no effector. The standard deviations represent the median of three separate transfections. Fig. 6 . HMGB1 effects on HIV-1 replication in Jurkat and THP-1 cells. (a) Mean p24 gag activity for pNL4-3 in the absence (indicated as no effector) or presence of 5 g of the HMGB1 sense (HMGB1-S) or the antisense HMGB1 (HMGB1-A) at day 1 to day 3 (shown as d-1, d-2, and d-3, respectively) posttransfection in cotransfected Jurkat cells. (b) p24 gag activity for the infectious clone in the absence or presence of 5 g of HMGB1-S or HMGB1-A at different days posttransfection (d-1 to d-3) in cotransfected THP-1 cells. The standard deviations are indicated as error bars. Supernatants from untransfected Jurkat or THP-1 cells were used as negative control (not shown).
tional biological anti-HIV-1 activity in this cell type to the same extent as was observed in HeLa cells.
Discussion
Here we found that ectopic overexpression of HMGB1 repressed HIV-1 gene expression in an epithelial cell line. We further investigated whether this inhibitory effect of HMGB1 was a result of repression of the HIV-1 LTRmediated transcription. We indicated that HMGB1 had a repressive effect on basal-, as well as Tat induced-transcription directed by the 5Ј-LTR in HeLa cells. This inhibitory effect of HMGB1 was LTR specific in the sense that HMGB1 in contrast stimulated the transcription from the SV 40 promoter/enhancer. In accordance with these findings, HMGB1 has been shown to stimulate transcription from other viral promoters such as the adenovirus major late promoter (MLTF) and the SV40 late promoter (Tremethick and Molloy, 1989) .
HMGB1 protein may downregulate HIV-1 LTR-mediated transcription by interacting with other cellular, and/or viral factors that directly or indirectly are involved in the viral transcription. HMGB1 has been shown to interact with several transcription regulatory proteins such as steroid hormone receptors, p53, Hox proteins, octamer transcription factors, the TATA binding protein (hTBP), and MLTF (for a review, see Bianchi and Beltrame, 2000) . In addition, HMGB1 regulates the activity of several transcription factors, including the glucocorticoid receptor (GR) (Calogero et al., 1999) as well as the receptor for the advanced glycation end products (RAGE) (Huttunen et al., 2000) through interaction with NFB. A general observation is that HMGB1 facilitates the assembly of site-specific DNA binding proteins to their cognate binding sites within the chromatin. The region of HMG box domain involved in the interaction with other proteins is still not known. It has recently been proposed that HMGB1 can interact with many apparently unrelated proteins by recognizing short amino acid sequences (Dintilhac and Bernues, 2002) . In the context of HIV-1 gene expression, another HMG protein, from the HMGA family (previously called HMGI), has been shown to modulate interaction of transcription factors to the U5 region of the 5ЈLTR of the virus (Henderson et al., 2000) .
Based on sequence homologies, DSP1 in Drosophila, which can convert members of the Rel family of transcription factors, NFB and the Drosophila protein Dorsal, from transcriptional activators to repressors (Lehming et al., 1994) , has been suggested to be the equivalent of vertebrate HMGB1 (Canaple et al., 1997) . Similar to DSP1, the HMG box in HMGB1 can also interact with the Rel domain of Dorsal (Brickman et al., 1999; Decoville et al., 2000) . Thus, we investigated a possible functional interaction between HMGB1 and NFB in the context of HIV-1 LTR. By deletion of the extra NFB site (NFBI) present in the LTR of subtype C viruses (Naghavi et al., 1999b (Naghavi et al., , 2001 , we could show a higher inhibitory activity of HMGB1 on the NFBI mutant subtype C LTR compared to the wt subtype C LTR. It should be noted that the interaction of HMGB1 with NFB alone cannot be the only explanation for HMGB1 repression of HIV-1 gene expression because several numbers of NFB sites are also present in the SV40 promoter/enhancer which, in contrast to the LTR, is stimulated by HMGB1. Thus, it can be speculated that a ternary complex forms between HMGB1, NFB, and another yet unidentified repressor(s) which directly or indirectly interact with a specific element in the LTR. In keeping with this idea, we have previously correlated a third potential NFB site and/or an alternative USF binding site (E-box) within the NRE in the LTR of HIV-1 subtype C to a higher promoter/enhancer activity (Naghavi et al., 1999b) . It has also been shown that a nuclear matrix-specific factor inhibits NFB activity through interaction with a specific segment within the NRE in HIV-1 infected T cells and monocytes (Hoover et al., 1996) . Also, a CCAAT/enhancer binding protein (C/EBP) in brain-derived cells can bind to the USF binding site within the NRE (E-box) and negatively regulate the HIV-1 promoter by interacting with NFB sites (Mondal et al., 1994) . In addition, the NRE region within the IFN-␤ promoter has been identified as a position independent silencer of the NFB sites (Nourbakhsh et al., 1993) . Furthermore, sequence similarity between core NREs of HIV-1, IFN-␤, and IL-2R␣ has been reported (Smith and Greene, 1989; Nourbakhsh et al., 1993) . Also in agreement with our speculation, the presence of a NRE adjacent to the Rel binding sites, as in the case of HIV-1 LTR and IL-2R␣ gene (Smith and Greene, 1989) , has been correlated to the "switching" function of DSP1 in the Drosophila Zen gene and interferon-␤ (IFN-␤) gene (Lehming et al., 1994) . However, a later report by the same group showed the inability of the NRE to mediate repression by Rel proteins (Brickman et al., 1999) . Whether the NRE in the HIV-1 LTR plays any role in the assembly of a NFB repressing complex remains to be elucidated.
We further investigated whether the inhibitory effect of HMGB1 on HIV-1 gene expression observed in epithelial cells could also be seen in the context of viral replication in T cells or monocytes. The level of viral replication was unchanged in the presence or the absence of the HMGB1-S vector in a transiently cotransfected monocytic cell line, THP-1, or in Jurkat cells. Western blot analysis on cell lysates from HeLa, Jurkat, and THP-1 using polyclonal antibodies against HMGB1 showed a higher level of endogenous HMGB1 in the latter cell lines compared to that of in HeLa cells (data not shown). Thus, HMGB1-S cotransfection might not add additional biological anti-HIV-1 activity in these cell types to the same extent as was observed in HeLa cells. Notably, a possible negative regulatory role of intracellular HMGB1 on HIV-1 replication was corroborated by results showing an upregulation of viral gene expression in the presence of an antisense HMGB1 construct in THP-1 cells. This effect of HMGB1 antisense was not observed in unstimulated Jurkat cells. However, in contrast to T cells, monocytes upon stimulation constitutively produce and secrete high amounts of HMGB1 (Wang et al., 1999) which could be blocked by the antisense HMGB1 mRNA in the cytoplasm of the cells. This could in turn lead to the upregulation of HIV-1 replication as observed. The monocytes in our cotransfection were most probably activated from the manipulations during the experiment. It was recently reported that extracellular HMGB1 stimulates proinflammatory cytokine synthesis such as TNF, IL-1, and macrophage inflammatory protein (MIP)-1␣ and MIP-1␤ in human monocytes (Andersson et al., 2000) . Secretion of the beta-chemokines has been correlated to the downregulation of newly HIV-1 infected human monocyte-derived macrophages (Barker et al., 1998) . The inhibitory effect of HMGB1 on viral gene expression observed in the present study could already be detected in a single round replication assay, i.e., within 24 h posttransfection of HeLa cells. Thus, the block of HIV-1 replication through the extracellular HMGB1 induced beta-chemokine induction is unlikely in our experimental set up because that would require more than one round of HIV-1 replication. On the other hand, as we suggested earlier, this finding may provide additional evidence that the HMGB1 inhibitory effect is mediated through NFB because there is no activated NFB in the nucleus of unstimulated Jurkat cells in contrast to HeLa cells or monocytes. This is supported by our preliminary finding showing a 4.5-fold upregulation of viral replication in the presence of 3 g of the antisense HMGB1 plasmid in cotransfected Jurkat cells after PMA stimulation (data not shown). However, our findings in Jurkat cells and monocytes seem to be insufficient for suggesting that HMGB1 plays a role in HIV-1 replication. To investigate this further, it would be interesting to determine HMGB1 activity in PBMCs and/or macrophages.
Data about HIV-1 biological activity, transmission, and pathogenicity is predominantly based on subtype B virus analysis, while subtypes C and E are the most prevalent subtypes in the world (UNAIDS/ WHO, 2000) . We (Johansson et al., 1995; Naghavi et al., 1999b Naghavi et al., , 2001 and others (Gao et al., 1996; Montano et al., 1997 Montano et al., , 1998 Montano et al., , 2000 Verhoef et al., 1999; Jeeninga et al., 2000; Blackard et al., 2000; Hunt et al., 2001) have indicated subtypes C and E specific LTR sequences such as different number of NFB sites, which we suggest here, to be of importance for HMGB1 inhibition of viral transcription. These viruses may have gained such subtype specific sequences to overcome the inhibitory effect of HMGB1 in monocytes. This may further explain the faster expansion and the global dominance of these viruses. As an explanation, we suggest that HMGB1 interaction with NFB may bring about a repression state of the chromatin at the LTR by recruiting other proteins necessary for repression. In keeping with this idea, the existence of a DSP1-associated putative transcriptional repressing complex, which can be recruited to DNA by interaction with various members of the Rel family of transcriptional activators, has been suggested (Lehming et al., 1998) . Constitutive HMGB1 mRNA expression in macrophages may therefore be involved in the control of HIV-1 replication, possibly functioning as a DSP1 homologue in these cells.
Materials and methods
PCR amplification and subcloning of human HMGB1
Recombinant human HMGB1, 651 base pair, was amplified from a human brain Quick-Clone cDNA (Clontech, Polo Alto, CA) using the following primers; forward primer: 5Ј-GATGGGCAAAGGAGATCCTAAG-3Ј and reverse primer: 5Ј-GCGGCCGCTTATTCATCATCATCATCTTC-3Ј. The PCR product was ligated into pCR2.1-TOPO vector (Invitrogen, San Diego, CA).
Plasmid constructs
The HMGB1 amplicon in the pCR2.1 vector was digested with EcoRI, dephosphorylated, and ligated into a mammalian expression vector, pcDNA3.1 (Ϫ) (Invitrogen). The pcDNA-HMGB1-sense (HMGB1-S) and pcDNA-HMGB1-antisense (HMGB1-A) constructs were identified directly by BamHI digestion and the positive clones were confirmed by sequencing. The full-length HIV-1 infectious clone containing LTR from a HIV-1 subtype C strain (GM6439:1C) has been described before (Naghavi et al., 2001 (Naghavi et al., , 1999a (Genbank accession number AF102202). pNL4-3 (Adachi et al., 1986) , pNLCATB (Tan et al., 1995) , pNLCATXSXB (Naghavi et al., 1999b ), pCMVHGH (Ramirez-Solis et al., 1990 , and pCMVCAT (Zhao et al., 1996) have been described previously. The pSV-␤-galactosidase (Promega, Modison, WI) control vector contains the SV40 promoter and enhancer, which drive transcription of the lacZ gene and further the expression of the ␤-galactosidase enzyme.
Mutant LTR
To generate HIV-1 subtype C LTR containing mutations in the potential third NFB site, the pCR2.1 vector containing LTR from subtype C (TA-6439:2) was used as template (Naghavi et al., 1999b) . The PCR was performed in two separate reactions containing oligonucleotides (1 M each) LTR1-SX and NFBI-EX-A (mix I) or LTR3-SB and NFBI-EX-S (mix II). LTR1-SX contains StuI and XhoI cloning sites and LTR3-SB contains SaII and BamHI sites as previously described (Naghavi et al., 1999b) . NFBI-EX-A and NFBI-EX-S primers are complementary and each contains a 12 bp substitution, which replace the extra NFB site (NFBI, position Ϫ79 to Ϫ68) (see Fig. 4 ) with EcoRV and XbaI sites. The sequences of these primers were as follows: NFBI-EX-A (5Ј-TCCACACCTCCTTCTAGAGATATC TGGAAAGTC-CCAGCGGAAAGTCCCTTCTGTGTC-3Ј) and NFBI-EX-S (5Ј-GACACAGAAGGGACTTTCCGCTGGGACTT-TCCAGATATCTCTAGAAGG AGGTGTGGA-3Ј). The restriction enzyme sites are underlined. Equal amounts of the two PCR fragments were mixed and used as template in a nested PCR reaction primed by addition of oligonucleotides LTR1-SX and LTR3-SB as previously described (Naghavi et al., 1999b) . The XhoI-BamHI PCR fragment was then transferred into pNLCATXSXB (Naghavi et al., 1999b) . The sequences of the NFBI mutant (6439C-mB) were confirmed by sequencing. To generate full-length HIV-1 clone containing subtype C LTR mutated in the extra NFB site (pNL6439C-mB), the resulting mutant LTR sequence was inserted as AatII-BssHII fragment into pNL4-3 as previously described (Naghavi et al., 1999b) .
Cells and transfections
For transfections, 0.5 ϫ 10 6 HeLa cells were seeded in each 60 mm dish 1 day before transfections. Transfection of HeLa cells was performed using FuGENE 6 transfection reagent (Boehringer Mannheim), adding 2 l reagent per g DNA. Transfection efficiency was normalized to human growth hormone (hGH) expressed from the cotransfected pCMVHGH internal control plasmid, which was present in all transfections, as described previously (Naghavi et al., 1999b) . One microgram of each pNL4-3-derived plasmid (wt subtype B and wt or NFBI-mutated subtype C) was mixed with 1 g of pCMVHGH in the presence or absence of 1-5 g of HMGB1-S or HMGB1-A or the empty plasmid (pcDNA). The total amount of DNA in each transfection was adjusted to 7 g by the addition of pBluescript DNA. The FuGENE 6 transfection reagent was added into the DNA mix according to the standard protocol (Boehringer Mannheim). Cell culture supernatants were collected at various times posttransfection (0, 24, 48, and 72 h) and hGH and HIV-1 p24 gag production were measured as described below. To look for the effect of HMGB1 on expression of the subtype C viruses containing wt or NFBImutated LTR, the respective pNL4-3-derived plasmid (pNL6439-wt and pNL6439C-mB, respectively) was included in the absence or presence of 5 g of the HMGB1-S or HMGB1-A in the cotransfection of HeLa cells as described above.
In order to analyze the effect of HMGB1 on the context of the LTR promoter, pNLCATB was included in the transfection of HeLa cells. Transfection was performed with the DNA-calcium phosphate coprecipitation technique as described previously (Naghavi et al., 1999b) . Three micrograms of each pNLCATB was mixed with 3 g of pCMVHGH in the presence or absence of 3-7 g of HMGB1-S or HMGB1-A or the empty plasmid (pcDNA). The total amount of DNA was filled up to 15 g by the addition of pBluescript DNA. To look for the HMGB1 effects on Tat trans-activated transcription, the HeLa-derived cell line HLtat which constitutively ex-presses a truncated 14 kDa functional form of Tat (Schwartz et al., 1990) , was used for transfections. Cells (4.5 ϫ 10 5 ) were seeded 1 day before transfections. The cells were cotransfected with 1 g of pNLCATB and 1 g of pCMVHGH in the presence or absence of 1-5 g of HMGB1-S or the empty plasmid. Transfection was carried out using FuGENE 6 (Boehringer Mannheim) according to the protocol described above. At 24 h posttransfection, cell lysates were obtained and analyzed as described before (Naghavi et al., 1999b) .
To investigate the effect of HMGB1 on the context of other viral promoters, HeLa cells were cotransfected with 1 g of pSV-␤-galactosidase (Promega) control vector or 1 g of pCMVCAT or 1 g of pCMVHGH (Ramirez-Solis et al., 1990) in the presence or absence of pCM-VHGH (1 g), HMGB1-S (1-5 g), HMGB1-A (1-5 g), or pcDNA (1-5 g). FuGENE 6 transfection reagent was used for transfection as described above. In the CAT and the hGH assay, the cells were harvested 24 h posttransfection and analyzed (see below). In the ␤-galactosidase assay, the cell culture supernatants were collected at 48 h posttransfection and tested in hGH ELISA. The cells were then harvested and analyzed for ␤-galactosidase activity as described below.
The human T cell lymphoma line Jurkat (ATCC) or the human acute monocytic leukemic cell line THP-1 (ATCC) was seeded at 0.7 ϫ 10 6 cells or 1.5 ϫ 10 6 cells per well in a 24-well dish, respectively. The next day, the cells were transfected using FuGENE 6 transfection reagent, as described for HeLa cells. Cell culture supernatants from replication assay were analyzed at different times posttransfection (day 1 to day 3) as described below. p24 gag , CAT, hGH, and ␤-galactosidase ELISA To determine the p24 gag levels produced in transfections with pNL4-3 derived plasmids, cell culture supernatants were analyzed directly in a p24 gag antigen capture HIVAG-1 ELISA (Abbott) according to the manufacturer's instructions. Cell culture supernatants adjusted to 1% Triton X-100 and appropriately diluted were analyzed in hGH ELISA to determine the transfection efficiency. The p24 concentrations (pg/ml) were normalized to hGH numbers. Cell extracts from the transfections in the absence (in HeLa) or presence of Tat (in HLtat) were diluted 10 and 1000 times, respectively, and further analyzed in CAT ELISA and hGH ELISA (Boehringer Mannheim) according to the manufacturer's instructions. The cell culture supernatant at 48 h posttransfection were diluted 10000 times and analyzed in hGH ELISA. The ␤-Galactosidase Enzyme Assay System (Promega) was performed on the cell lysates from the transfections following the standard protocol. The CAT and ␤-galactosidase numbers were normalized to hGH values. Each LTR, CMV, or SV40 promoter was tested in triplicates in at least two independent experiments.
